These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34447745)

  • 1. Investigating Optimal Autologous Cellular Platforms for Prenatal or Perinatal Factor VIII Delivery to Treat Hemophilia A.
    Stem C; Rodman C; Ramamurthy RM; George S; Meares D; Farland A; Atala A; Doering CB; Spencer HT; Porada CD; Almeida-Porada G
    Front Cell Dev Biol; 2021; 9():678117. PubMed ID: 34447745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Utero Transplantation of Placenta-Derived Mesenchymal Stromal Cells for Potential Fetal Treatment of Hemophilia A.
    Kumar P; Gao K; Wang C; Pivetti C; Lankford L; Farmer D; Wang A
    Cell Transplant; 2018 Jan; 27(1):130-139. PubMed ID: 29562772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the Optimal FVIII Transgene for Placental Cell-Based Gene Therapy to Treat Hemophilia A.
    El-Akabawy N; Rodriguez M; Ramamurthy R; Rabah A; Trevisan B; Morsi A; George S; Shields J; Meares D; Farland A; Atala A; Doering CB; Spencer HT; Porada CD; Almeida-Porada G
    Mol Ther Methods Clin Dev; 2020 Jun; 17():465-477. PubMed ID: 32258210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of different gene addition strategies to modify placental derived-mesenchymal stromal cells to produce FVIII.
    Ramamurthy RM; Rodriguez M; Ainsworth HC; Shields J; Meares D; Bishop C; Farland A; Langefeld CD; Atala A; Doering CB; Spencer HT; Porada CD; Almeida-Porada G
    Front Immunol; 2022; 13():954984. PubMed ID: 36591257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved intravenous lentiviral gene therapy based on endothelial-specific promoter-driven factor VIII expression for hemophilia A.
    Gong J; Yang R; Zhou M; Chang LJ
    Mol Med; 2023 Jun; 29(1):74. PubMed ID: 37308845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioengineering hemophilia A-specific microvascular grafts for delivery of full-length factor VIII into the bloodstream.
    Neumeyer J; Lin RZ; Wang K; Hong X; Hua T; Croteau SE; Neufeld EJ; Melero-Martin JM
    Blood Adv; 2019 Dec; 3(24):4166-4176. PubMed ID: 31851760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemophilia A gene therapy via intraosseous delivery of factor VIII-lentiviral vectors.
    Miao CH
    Thromb J; 2016; 14(Suppl 1):41. PubMed ID: 27766066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ectopic Expression of FVIII in HPCs and MSCs Derived from hiPSCs with Site-Specific Integration of
    Zhao J; Zhou M; Wang Z; Wu L; Hu Z; Liang D
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial cells derived from patients' induced pluripotent stem cells for sustained factor VIII delivery and the treatment of hemophilia A.
    Rose M; Gao K; Cortez-Toledo E; Agu E; Hyllen AA; Conroy K; Pan G; Nolta JA; Wang A; Zhou P
    Stem Cells Transl Med; 2020 Jun; 9(6):686-696. PubMed ID: 32162786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B Cell Depletion Eliminates FVIII Memory B Cells and Enhances AAV8-coF8 Immune Tolerance Induction When Combined With Rapamycin.
    Biswas M; Palaschak B; Kumar SRP; Rana J; Markusic DM
    Front Immunol; 2020; 11():1293. PubMed ID: 32670285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraosseous delivery of lentiviral vectors targeting factor VIII expression in platelets corrects murine hemophilia A.
    Wang X; Shin SC; Chiang AF; Khan I; Pan D; Rawlings DJ; Miao CH
    Mol Ther; 2015 Apr; 23(4):617-26. PubMed ID: 25655313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of GPIbα on platelet-targeted FVIII gene therapy in hemophilia A mice with pre-existing anti-FVIII immunity.
    Chen J; Schroeder JA; Luo X; Montgomery RR; Shi Q
    J Thromb Haemost; 2019 Mar; 17(3):449-459. PubMed ID: 30609275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow mesenchymal cells for haemophilia A gene therapy using retroviral vectors with modified long-terminal repeats.
    Van Damme A; Chuah MK; Dell'accio F; De Bari C; Luyten F; Collen D; VandenDriessche T
    Haemophilia; 2003 Jan; 9(1):94-103. PubMed ID: 12558785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD14+/CD31+ monocytes expanded by UM171 correct hemophilia A in zebrafish upon lentiviral gene transfer of factor VIII.
    Elnaggar M; Al-Mohannadi A; Hasan W; Abdelrahman D; Al-Kubaisi MJ; Pavlovski I; Gentilcore G; Sathappan A; Kizhakayil D; Ali AI; Mohan S; Olagunju D; Cugno C; Grivel JC; Borsotti C; Follenzi A; Da'as SI; Deola S
    Blood Adv; 2023 Mar; 7(5):697-711. PubMed ID: 36477543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mesenchymal stem cells derived from transgenic mice carrying human coagulation factor VIII can correct phenotype in hemophilia A mice.
    Wang Q; Gong X; Gong Z; Ren X; Ren Z; Huang S; Zeng Y
    J Genet Genomics; 2013 Dec; 40(12):617-28. PubMed ID: 24377868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of an optimized lentiviral vector encoding a high-expression factor VIII transgene for gene therapy of hemophilia A.
    Johnston JM; Denning G; Doering CB; Spencer HT
    Gene Ther; 2013 Jun; 20(6):607-15. PubMed ID: 22996197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a genetically engineered mouse model of hemophilia A with complete deletion of the F8 gene.
    Chao BN; Baldwin WH; Healey JF; Parker ET; Shafer-Weaver K; Cox C; Jiang P; Kanellopoulou C; Lollar P; Meeks SL; Lenardo MJ
    J Thromb Haemost; 2016 Feb; 14(2):346-55. PubMed ID: 26588198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoration of FVIII Function and Phenotypic Rescue in Hemophilia A Mice by Transplantation of MSCs Derived From
    Qiu L; Xie M; Zhou M; Liu X; Hu Z; Wu L
    Front Cell Dev Biol; 2021; 9():630353. PubMed ID: 33644070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of improved factor VIII molecules and new gene transfer approaches for hemophilia A.
    Saenko EL; Ananyeva NM; Moayeri M; Ramezani A; Hawley RG
    Curr Gene Ther; 2003 Feb; 3(1):27-41. PubMed ID: 12553533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vitro FVIII-Encoding Transgenic Mesenchymal Stem Cells Maintain Successful Coagulation in FVIII-Deficient Plasma Mimicking Hemophilia A.
    Hemşinlioğlu C; Aslan ES; Taştan C; Çakırsoy D; Turan RD; Seyis U; Elek M; Sır Karakuş G; Günaydın ÖS; Abanuz S; Kançağı DD; Yurtsever B; Yalçın K; Kasap M; Ovalı E
    Turk J Haematol; 2023 May; 40(2):118-124. PubMed ID: 37022209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.